BWA
PTCT icon

BDO Wealth Advisors’s PTC Therapeutics PTCT Stock Holding History

BDO Wealth Advisors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50
Closed -$3K – 932
2020
Q2 		$3K Hold
50
– – ﹤0.01% 604
2020
Q1 		$2K Buy
+50
New +$2.52K ﹤0.01% 682

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BDO Wealth Advisors's PTCT Position: Q3 2020 in Review

BDO Wealth Advisors sold out of PTC Therapeutics (PTCT) in Q3 2020, closing a stake of 50 shares — an estimated $3K sold.

BDO Wealth Advisors first reported a position in PTCT in Q1 2020 and held it in 2 quarters. The position peaked at $3K in Q2 2020. 196 funds tracked by Wall St. Rank hold PTCT as of Q3 2020.

  • BDO Wealth Advisors reported no remaining PTC Therapeutics position as of Q3 2020 after selling out during the quarter.
  • BDO Wealth Advisors sold 50 PTC Therapeutics shares in Q3 2020, an estimated $3K.
  • BDO Wealth Advisors first reported a position in PTC Therapeutics in Q1 2020 and held it in 2 quarters.
  • BDO Wealth Advisors's PTC Therapeutics position peaked at $3K in Q2 2020.
  • 196 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2020.

Based on BDO Wealth Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.